Cancer-related fatigue

Ann M. Berger, Amy Pickar Abernethy, Ashley Atkinson, Andrea M. Barsevick, William S. Breitbart, David Cella, Bernadine Cimprich, Charles Cleeland, Mario A. Eisenberger, Carmen P. Escalante, Paul B. Jacobsen, Phyllis Kaldor, Jennifer A. Ligibel, Barbara A. Murphy, Tracey O'Connor, William F. Pirl, Eve Rodler, Hope S. Rugo, Jay Thomas, Lynne I. Wagner

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

These guidelines propose a treatment algorithm in which patients are evaluated regularly for fatigue using a brief screening instrument and are treated as indicated by their fatigue level. Management of fatigue begins with primary oncology team members who perform the initial screening and either provide basic education and counseling or expand the initial screening to a more focused evaluation for moderate or higher levels of fatigue. At this point, the patient is assessed for current disease and treatment status and undergoes a review of body systems and an in-depth fatigue evaluation. In addition, the patient is assessed for the presence of treatable factors known to contribute to fatigue. If any of these conditions are present, they should be treated according to practice guidelines, with referral to other care professionals as appropriate, and the patient's fatigue should be reevaluated regularly. If none of the factors are present or if the fatigue is unresolved, appropriate fatigue management and treatment strategies are selected based on the patient's clinical status (e.g., undergoing active cancer treatment, posttreatment, at the end of life). Management of fatigue is cause-specific when conditions known to cause fatigue can be identified and treated. When specific causes of fatigue cannot be identified and corrected, the fatigue can still be treated with nonpharmacologic and pharmacologic interventions. Nonpharmacologic interventions may include a moderate exercise program to improve functional capacity and activity tolerance, psychosocial programs to manage stress and increase support, energy conservation to maintain energy, and nutritional and sleep interventions for patients with disturbances in eating or sleeping. Pharmacologic therapy may include drugs, such as antidepressants for depression or erythropoietin for anemia. A few clinical reports suggest the need for further research on the use of psychostimulants as potential treatment modalities for managing fatigue. Effective management of cancer-related fatigue involves an informed and supportive oncology care team that assesses patients' fatigue levels regularly, counsels and educates patients regarding strategies for coping with fatigue,216 and refers patients with unresolved fatigue to institutional experts.45 The oncology care team must recognize the many patient-, provider-, and system-related behaviors that can impede effective fatigue management. Using available resources and evidence-based guidelines to reduce barriers increases benefits to patients experiencing fatigue. 217,218

Original languageEnglish (US)
Pages (from-to)904-931
Number of pages28
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume8
Issue number8
StatePublished - Aug 2010
Externally publishedYes

Fingerprint

Fatigue
Neoplasms
Therapeutics
Guidelines
Patient Care Team
Erythropoietin
Practice Guidelines
Antidepressive Agents

Keywords

  • Bone marrow transplantation
  • Carcinoma treatment
  • Chemotherapy
  • Evaluation
  • Fatigue
  • Intervention
  • NCCN clinical practice guidelines
  • NCCN guidelines
  • Radiation therapy
  • Screening

ASJC Scopus subject areas

  • Oncology

Cite this

Berger, A. M., Abernethy, A. P., Atkinson, A., Barsevick, A. M., Breitbart, W. S., Cella, D., ... Wagner, L. I. (2010). Cancer-related fatigue. JNCCN Journal of the National Comprehensive Cancer Network, 8(8), 904-931.

Cancer-related fatigue. / Berger, Ann M.; Abernethy, Amy Pickar; Atkinson, Ashley; Barsevick, Andrea M.; Breitbart, William S.; Cella, David; Cimprich, Bernadine; Cleeland, Charles; Eisenberger, Mario A.; Escalante, Carmen P.; Jacobsen, Paul B.; Kaldor, Phyllis; Ligibel, Jennifer A.; Murphy, Barbara A.; O'Connor, Tracey; Pirl, William F.; Rodler, Eve; Rugo, Hope S.; Thomas, Jay; Wagner, Lynne I.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 8, No. 8, 08.2010, p. 904-931.

Research output: Contribution to journalArticle

Berger, AM, Abernethy, AP, Atkinson, A, Barsevick, AM, Breitbart, WS, Cella, D, Cimprich, B, Cleeland, C, Eisenberger, MA, Escalante, CP, Jacobsen, PB, Kaldor, P, Ligibel, JA, Murphy, BA, O'Connor, T, Pirl, WF, Rodler, E, Rugo, HS, Thomas, J & Wagner, LI 2010, 'Cancer-related fatigue', JNCCN Journal of the National Comprehensive Cancer Network, vol. 8, no. 8, pp. 904-931.
Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D et al. Cancer-related fatigue. JNCCN Journal of the National Comprehensive Cancer Network. 2010 Aug;8(8):904-931.
Berger, Ann M. ; Abernethy, Amy Pickar ; Atkinson, Ashley ; Barsevick, Andrea M. ; Breitbart, William S. ; Cella, David ; Cimprich, Bernadine ; Cleeland, Charles ; Eisenberger, Mario A. ; Escalante, Carmen P. ; Jacobsen, Paul B. ; Kaldor, Phyllis ; Ligibel, Jennifer A. ; Murphy, Barbara A. ; O'Connor, Tracey ; Pirl, William F. ; Rodler, Eve ; Rugo, Hope S. ; Thomas, Jay ; Wagner, Lynne I. / Cancer-related fatigue. In: JNCCN Journal of the National Comprehensive Cancer Network. 2010 ; Vol. 8, No. 8. pp. 904-931.
@article{9e1e35ce49b346fba589f9d1cc1da277,
title = "Cancer-related fatigue",
abstract = "These guidelines propose a treatment algorithm in which patients are evaluated regularly for fatigue using a brief screening instrument and are treated as indicated by their fatigue level. Management of fatigue begins with primary oncology team members who perform the initial screening and either provide basic education and counseling or expand the initial screening to a more focused evaluation for moderate or higher levels of fatigue. At this point, the patient is assessed for current disease and treatment status and undergoes a review of body systems and an in-depth fatigue evaluation. In addition, the patient is assessed for the presence of treatable factors known to contribute to fatigue. If any of these conditions are present, they should be treated according to practice guidelines, with referral to other care professionals as appropriate, and the patient's fatigue should be reevaluated regularly. If none of the factors are present or if the fatigue is unresolved, appropriate fatigue management and treatment strategies are selected based on the patient's clinical status (e.g., undergoing active cancer treatment, posttreatment, at the end of life). Management of fatigue is cause-specific when conditions known to cause fatigue can be identified and treated. When specific causes of fatigue cannot be identified and corrected, the fatigue can still be treated with nonpharmacologic and pharmacologic interventions. Nonpharmacologic interventions may include a moderate exercise program to improve functional capacity and activity tolerance, psychosocial programs to manage stress and increase support, energy conservation to maintain energy, and nutritional and sleep interventions for patients with disturbances in eating or sleeping. Pharmacologic therapy may include drugs, such as antidepressants for depression or erythropoietin for anemia. A few clinical reports suggest the need for further research on the use of psychostimulants as potential treatment modalities for managing fatigue. Effective management of cancer-related fatigue involves an informed and supportive oncology care team that assesses patients' fatigue levels regularly, counsels and educates patients regarding strategies for coping with fatigue,216 and refers patients with unresolved fatigue to institutional experts.45 The oncology care team must recognize the many patient-, provider-, and system-related behaviors that can impede effective fatigue management. Using available resources and evidence-based guidelines to reduce barriers increases benefits to patients experiencing fatigue. 217,218",
keywords = "Bone marrow transplantation, Carcinoma treatment, Chemotherapy, Evaluation, Fatigue, Intervention, NCCN clinical practice guidelines, NCCN guidelines, Radiation therapy, Screening",
author = "Berger, {Ann M.} and Abernethy, {Amy Pickar} and Ashley Atkinson and Barsevick, {Andrea M.} and Breitbart, {William S.} and David Cella and Bernadine Cimprich and Charles Cleeland and Eisenberger, {Mario A.} and Escalante, {Carmen P.} and Jacobsen, {Paul B.} and Phyllis Kaldor and Ligibel, {Jennifer A.} and Murphy, {Barbara A.} and Tracey O'Connor and Pirl, {William F.} and Eve Rodler and Rugo, {Hope S.} and Jay Thomas and Wagner, {Lynne I.}",
year = "2010",
month = "8",
language = "English (US)",
volume = "8",
pages = "904--931",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "8",

}

TY - JOUR

T1 - Cancer-related fatigue

AU - Berger, Ann M.

AU - Abernethy, Amy Pickar

AU - Atkinson, Ashley

AU - Barsevick, Andrea M.

AU - Breitbart, William S.

AU - Cella, David

AU - Cimprich, Bernadine

AU - Cleeland, Charles

AU - Eisenberger, Mario A.

AU - Escalante, Carmen P.

AU - Jacobsen, Paul B.

AU - Kaldor, Phyllis

AU - Ligibel, Jennifer A.

AU - Murphy, Barbara A.

AU - O'Connor, Tracey

AU - Pirl, William F.

AU - Rodler, Eve

AU - Rugo, Hope S.

AU - Thomas, Jay

AU - Wagner, Lynne I.

PY - 2010/8

Y1 - 2010/8

N2 - These guidelines propose a treatment algorithm in which patients are evaluated regularly for fatigue using a brief screening instrument and are treated as indicated by their fatigue level. Management of fatigue begins with primary oncology team members who perform the initial screening and either provide basic education and counseling or expand the initial screening to a more focused evaluation for moderate or higher levels of fatigue. At this point, the patient is assessed for current disease and treatment status and undergoes a review of body systems and an in-depth fatigue evaluation. In addition, the patient is assessed for the presence of treatable factors known to contribute to fatigue. If any of these conditions are present, they should be treated according to practice guidelines, with referral to other care professionals as appropriate, and the patient's fatigue should be reevaluated regularly. If none of the factors are present or if the fatigue is unresolved, appropriate fatigue management and treatment strategies are selected based on the patient's clinical status (e.g., undergoing active cancer treatment, posttreatment, at the end of life). Management of fatigue is cause-specific when conditions known to cause fatigue can be identified and treated. When specific causes of fatigue cannot be identified and corrected, the fatigue can still be treated with nonpharmacologic and pharmacologic interventions. Nonpharmacologic interventions may include a moderate exercise program to improve functional capacity and activity tolerance, psychosocial programs to manage stress and increase support, energy conservation to maintain energy, and nutritional and sleep interventions for patients with disturbances in eating or sleeping. Pharmacologic therapy may include drugs, such as antidepressants for depression or erythropoietin for anemia. A few clinical reports suggest the need for further research on the use of psychostimulants as potential treatment modalities for managing fatigue. Effective management of cancer-related fatigue involves an informed and supportive oncology care team that assesses patients' fatigue levels regularly, counsels and educates patients regarding strategies for coping with fatigue,216 and refers patients with unresolved fatigue to institutional experts.45 The oncology care team must recognize the many patient-, provider-, and system-related behaviors that can impede effective fatigue management. Using available resources and evidence-based guidelines to reduce barriers increases benefits to patients experiencing fatigue. 217,218

AB - These guidelines propose a treatment algorithm in which patients are evaluated regularly for fatigue using a brief screening instrument and are treated as indicated by their fatigue level. Management of fatigue begins with primary oncology team members who perform the initial screening and either provide basic education and counseling or expand the initial screening to a more focused evaluation for moderate or higher levels of fatigue. At this point, the patient is assessed for current disease and treatment status and undergoes a review of body systems and an in-depth fatigue evaluation. In addition, the patient is assessed for the presence of treatable factors known to contribute to fatigue. If any of these conditions are present, they should be treated according to practice guidelines, with referral to other care professionals as appropriate, and the patient's fatigue should be reevaluated regularly. If none of the factors are present or if the fatigue is unresolved, appropriate fatigue management and treatment strategies are selected based on the patient's clinical status (e.g., undergoing active cancer treatment, posttreatment, at the end of life). Management of fatigue is cause-specific when conditions known to cause fatigue can be identified and treated. When specific causes of fatigue cannot be identified and corrected, the fatigue can still be treated with nonpharmacologic and pharmacologic interventions. Nonpharmacologic interventions may include a moderate exercise program to improve functional capacity and activity tolerance, psychosocial programs to manage stress and increase support, energy conservation to maintain energy, and nutritional and sleep interventions for patients with disturbances in eating or sleeping. Pharmacologic therapy may include drugs, such as antidepressants for depression or erythropoietin for anemia. A few clinical reports suggest the need for further research on the use of psychostimulants as potential treatment modalities for managing fatigue. Effective management of cancer-related fatigue involves an informed and supportive oncology care team that assesses patients' fatigue levels regularly, counsels and educates patients regarding strategies for coping with fatigue,216 and refers patients with unresolved fatigue to institutional experts.45 The oncology care team must recognize the many patient-, provider-, and system-related behaviors that can impede effective fatigue management. Using available resources and evidence-based guidelines to reduce barriers increases benefits to patients experiencing fatigue. 217,218

KW - Bone marrow transplantation

KW - Carcinoma treatment

KW - Chemotherapy

KW - Evaluation

KW - Fatigue

KW - Intervention

KW - NCCN clinical practice guidelines

KW - NCCN guidelines

KW - Radiation therapy

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=77957580217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957580217&partnerID=8YFLogxK

M3 - Article

C2 - 20870636

AN - SCOPUS:77957580217

VL - 8

SP - 904

EP - 931

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 8

ER -